Medical and Biological Sciences Building, School of Medicine, University of St Andrews, St Andrews, UK.
Oncogene. 2013 Apr 4;32(14):1821-30. doi: 10.1038/onc.2012.196. Epub 2012 May 21.
The Salvador/Warts/Hippo (Hippo) signaling pathway defines a novel signaling cascade regulating cell contact inhibition, organ size control, cell growth, proliferation, apoptosis and cancer development in mammals. The upstream regulation of this pathway has been less well defined than the core kinase cassette. KIBRA has been shown to function as an upstream member of the Hippo pathway by influencing the phosphorylation of LATS and YAP, but functional consequences of these biochemical changes have not been previously addressed. We show that in MCF10A cells, loss of KIBRA expression displays epithelial-to-mesenchymal transition (EMT) features, which are concomitant with decreased LATS and YAP phosphorylation, but not MST1/2. In addition, ectopic KIBRA expression antagonizes YAP via the serine 127 phosphorylation site and we show that KIBRA, Willin and Merlin differentially regulate genes controlled by YAP. Finally, reduced KIBRA expression in primary breast cancer specimens correlates with the recently described claudin-low subtype, an aggressive sub-group with EMT features and a poor prognosis.
Salvador/Warts/Hippo (Hippo) 信号通路定义了一个新的信号级联,调节哺乳动物细胞接触抑制、器官大小控制、细胞生长、增殖、凋亡和癌症发展。该通路的上游调控比核心激酶盒的调控研究得更少。KIBRA 已被证明是 Hippo 通路的上游成员,通过影响 LATS 和 YAP 的磷酸化,但这些生化变化的功能后果尚未得到解决。我们发现,在 MCF10A 细胞中,KIBRA 表达的缺失表现出上皮-间充质转化 (EMT) 的特征,这与 LATS 和 YAP 磷酸化的减少有关,但与 MST1/2 无关。此外,外源性 KIBRA 表达通过丝氨酸 127 磷酸化位点拮抗 YAP,我们发现 KIBRA、Willin 和 Merlin 差异调节 YAP 控制的基因。最后,在原发性乳腺癌标本中,KIBRA 表达的减少与最近描述的 Claudin-low 亚型相关,这是一个具有 EMT 特征和预后不良的侵袭性亚组。